Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +1.55% slipped 3.03% to $152.54 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.07% falling 2.28% to 13,539.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.12% falling 0.19% to 34,297.73. This was the stock's eighth consecutive day of losses. Moderna Inc. closed $344.95 below its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +2.57% rose 0.70% to $133.09, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.77% fell 0.46% to $225.04, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.34% rose 1.54% to $57.85. Trading volume (11.3 M) remained 107,612 below its 50-day average volume of 11.4 M.